
Prodizen, a regenerative medicine company, successfully held "K-Bio Global Medical Training" with Canada's Clarion Medical Technologies, a global medical device distributor, at HOAN CLINIC in Hannam-dong, Seoul on September 25, and took a full-fledged step toward the global market.
The event was organized to directly showcase the excellence of Prodizen's flagship PRP kit to global partners. Clarion is a company distributing the World PRP (World PRP) brand to countries around the world in the PRP field, and Clarion officials directly confirmed the strength of Prodizen's products such as stable platelet separation, high recovery rate, and ease of use.
Hoan Clinic is a medical institution specializing in domestic PRP and regenerative medicine, and it has opened a venue for exchanges with global medical staff by unveiling an international-level clinical environment along with actual medical staff demonstrations, proving the global competitiveness and practical use of Korean PRP solutions.
Clarion Medical Technologies is a Canada-based company that supplies beauty and regenerative medicine devices to the global market, and its strength is that it successfully distributes Platelet-Rich Plasma (PRP) solutions to the international market through the World PRP (World PRP) brand and has professional manpower and network who are fluent in product licensing and market entry strategies.
Through this strategic partnership with Clarion, Prodizen has already signed exclusive distribution contracts in major regions such as Europe, the Middle East, and Oceania. The fact that Clarion chose Prodizen among the numerous PRP manufacturers proves the product's quality competitiveness and technology reliability, and through this cooperation, the two companies are expected to strengthen the international distribution of PRP products and strengthen their long-term global business foundation.
"K-Bio's innovation no longer stays in Korea," a Prodigy official said. "We will continue to make efforts to establish Korea's PRP technology as a global standard with this global training."
Meanwhile, Prodizen, founded in 1998, succeeded in localizing PRP kits for the first time in Korea and is currently exporting products to about 30 countries around the world based on a simple and fast high-enriched PRP extraction system based on steady technology accumulation and quality management system through its own GMP facility.
Currently, U.S. patent applications are underway, and as a global regenerative medical solution company focusing on developing customized solutions to meet the needs of medical sites, it has achieved high market performance by exporting major product lines, including PRP kits, to various countries such as the U.S., Europe, the Middle East, and Asia.
[Bio-Times = Reporter Jung Min-koo] news@biotimes.co.kr